Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,145 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $690.59 | 27 | $0 (2022) |
| Gilead Sciences, Inc. | $143.79 | 7 | $0 (2023) |
| Dynavax Technologies Corporation | $115.41 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $73.80 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $65.94 | 5 | $0 (2018) |
| Allergan Inc. | $21.49 | 1 | $0 (2017) |
| Cumberland Pharmaceuticals, Inc. | $12.03 | 1 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $10.90 | 1 | $0 (2019) |
| TETRAPHASE PHARMACEUTICALS, INC. | $10.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $44.96 | 2 | Gilead Sciences, Inc. ($44.96) |
| 2022 | $84.43 | 4 | ViiV Healthcare Company ($39.06) |
| 2021 | $26.41 | 2 | Janssen Biotech, Inc. ($26.41) |
| 2020 | $68.19 | 3 | ViiV Healthcare Company ($68.19) |
| 2019 | $100.96 | 7 | ViiV Healthcare Company ($51.53) |
| 2018 | $306.67 | 12 | Dynavax Technologies Corporation ($115.41) |
| 2017 | $513.23 | 19 | ViiV Healthcare Company ($428.87) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.79 | General |
| 05/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 11/28/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: HIV | ||||||
| 09/07/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.59 | General |
| 04/27/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/29/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: HIV | ||||||
| 08/30/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/04/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/18/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: HIV | ||||||
| 10/20/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: HIV | ||||||
| 08/26/2020 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $18.63 | General |
| 11/20/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 11/18/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.60 | General |
| 09/18/2019 | Cumberland Pharmaceuticals, Inc. | Vibativ (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: HIV | ||||||
| 04/24/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: HIV | ||||||
| 04/22/2019 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $10.90 | General |
| 03/29/2019 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 08/24/2018 | Dynavax Technologies Corporation | HEPLISAV-B (Drug) | Food and Beverage | In-kind items and services | $115.41 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/27/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/20/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.62 | General |
| 06/04/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 03/05/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: HIV | ||||||
| 02/23/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: HIV | ||||||
| 02/09/2018 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 165 | 213 | $37,055 | $13,312 |
| 2022 | 6 | 188 | 241 | $43,021 | $15,469 |
| 2021 | 6 | 289 | 388 | $62,531 | $23,021 |
| 2020 | 8 | 319 | 454 | $72,031 | $26,395 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 72 | $20,448 | $7,029 | 34.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 58 | 97 | $9,991 | $3,734 | 37.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 28 | $4,088 | $1,660 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,528 | $889.68 | 35.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 54 | $15,336 | $5,693 | 37.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 51 | 82 | $8,446 | $2,479 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 44 | $6,424 | $2,449 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 34 | $4,964 | $1,850 | 37.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,411 | $1,699 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $3,440 | $1,299 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 105 | $15,330 | $5,969 | 38.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 50 | 50 | $14,239 | $5,376 | 37.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 84 | 131 | $13,493 | $3,982 | 29.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 46 | 46 | $9,706 | $3,670 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 23 | $4,945 | $2,035 | 41.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 33 | $4,818 | $1,988 | 41.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 96 | 195 | $28,470 | $11,262 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 65 | 66 | $18,744 | $7,236 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 87 | $12,702 | $3,747 | 29.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 38 | 40 | $8,440 | $3,240 | 38.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 15 | $401.66 | $240.05 | 59.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $396.00 | $232.17 | 58.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 16 | 17 | $1,513 | $225.20 | 14.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 21 | 22 | $1,364 | $212.48 | 15.6% |
About Dr. Dean Markham, M.D
Dr. Dean Markham, M.D is a Infectious Disease healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871548032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Markham, M.D has received a total of $1,145 in payments from pharmaceutical and medical device companies, with $44.96 received in 2023. These payments were reported across 49 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,145).
As a Medicare-enrolled provider, Markham has provided services to 961 Medicare beneficiaries, totaling 1,296 services with total Medicare billing of $78,197. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Greenville, NC
- Active Since 05/24/2006
- Last Updated 02/20/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1871548032
Products in Payments
- TRIUMEQ (Drug) $188.81
- HEPLISAV-B (Drug) $115.41
- DOVATO (Drug) $104.45
- JULUCA (Drug) $62.50
- SYMTUZA (Drug) $45.19
- ZERBAXA (Drug) $31.48
- PREZCOBIX (Drug) $28.61
- ISENTRESS (Drug) $23.30
- AVYCAZ (Drug) $21.49
- CABENUVA (Biological) $20.75
- Vibativ (Drug) $12.03
- Xerava (Drug) $10.90
- TIVICAY (Drug) $10.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Greenville
John Schrank, M.d, M.D
Infectious Disease — Payments: $90,439
Dr. Paul Cook, Md, MD
Infectious Disease — Payments: $16,045
Alexandra Stang, M.d, M.D
Infectious Disease — Payments: $13,989
John Kelly, M.d, M.D
Infectious Disease — Payments: $7,793
Satwinder Singh, Md, MD
Infectious Disease — Payments: $2,796
Rhett Shirley, Md, MD
Infectious Disease — Payments: $2,484